ArticleOncogene2019
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.
Francesco Alessandrini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
this paperpooled itcites it